Welcome to our dedicated page for Zions Bancorpora SEC filings (Ticker: ZIONP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zions Bancorporation, N.A. Depositary Shares (NASDAQ: ZIONP) are backed by the bank’s Series A floating-rate non-cumulative perpetual preferred stock, with each ZIONP share representing a 1/40th interest in an underlying preferred share. This SEC filings page aggregates regulatory documents filed by Zions Bancorporation, N.A., the issuer behind ZIONP, giving investors a way to review the bank’s disclosed financial condition and corporate actions that may be relevant to holders of the Series A preferred securities.
Zions Bancorporation, N.A. submits periodic and current reports to the U.S. Securities and Exchange Commission, including Forms 10-K and 10-Q for annual and quarterly reporting, and Forms 8-K for material events. For example, the bank has filed a Form 8-K to announce quarterly financial results and to furnish related presentation materials. These filings provide context on the bank’s operations, capital structure, and earnings, which are important considerations when evaluating a preferred equity instrument such as ZIONP.
On this page, users can access SEC documents that cover the issuer’s financial statements, risk disclosures, and other regulatory information. Filings related to capital and equity, including descriptions of preferred stock, can help clarify the terms and position of the Series A preferred within the bank’s overall capital framework. In addition, Forms 4 and other ownership-related filings, when available, offer insight into insider transactions at the issuer level.
Stock Titan enhances these filings with AI-powered summaries that explain key sections in plain language, highlight important changes from prior periods, and draw attention to items that may matter for preferred shareholders. Real-time updates from EDGAR help ensure that new Zions Bancorporation, N.A. filings are reflected promptly, allowing users to review 10-Ks, 10-Qs, 8-Ks, and other documents as they become available.
Zions Bancorporation executive Steven Dan Stephens reported exercising stock options and selling common shares on 02/06/2026. He sold 4,000 common shares at a weighted average price of $65.91 and later sold 4,769 and 6,707 shares at weighted average prices around $65.90.
On the same date, he exercised stock options for 2,106 and 4,769 shares at an exercise price of $51.17, and 6,707 shares at $45.65. After these transactions, he directly owned 43,233 shares of common stock.
A shareholder of the company with ticker ZION has filed a notice of proposed sale under Rule 144 for 15,476 shares of common stock through Fidelity Brokerage Services LLC on 02/06/2026, to be sold on NASDAQ at an aggregate market value of 1019924.99.
The filing notes that 1,046 shares were acquired via restricted stock vesting and 2,954 shares via stock option exercise on 02/12/2025, and that 4,769 and 6,707 shares were acquired on 02/06/2026 through options originally granted in 2019 and 2020, with payment described as compensation or cash.
A shareholder of ZION filed notice of intent to sell common stock under Rule 144. The filing covers 16,998 shares with an aggregate market value of 1121477.04, to be sold on or about 02/06/2026 through Fidelity Brokerage Services on the NASDAQ.
The shares were acquired on 02/06/2026 via an option originally granted on 02/08/2021, paid for in cash. During the prior three months, the same seller disposed of 11,663 shares for 721751.01 and 16,085 shares for 1029440.00. The seller represents not knowing any undisclosed material adverse information about the issuer.
A holder of ZION common stock has filed a Rule 144 notice to sell 6,558 shares. The planned sale, through Fidelity Brokerage Services LLC on NASDAQ, has an aggregate market value of $424,958.40 and is targeted for 02/06/2026.
The filing notes that 147,641,034 common shares were outstanding. The shares to be sold were acquired over time via dividend reinvestments and restricted stock vesting, with several grants treated as compensation from the issuer.
Paul E. Burdiss filed a Rule 144 notice to sell 16,085 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $1,029,440.00, on or about 02/05/2026 on the NASDAQ.
The shares to be sold were acquired on 02/05/2026 via an option granted on 02/10/2020 by the issuer and paid for in cash. Over the prior three months, Burdiss sold 11,663 common shares on 02/03/2026 for gross proceeds of $721,751.01. The filing also notes total shares outstanding of 147,641,034.
Zions Bancorporation, National Association executive Rena A. Miller, Executive VP & General Counsel, reported multiple equity transactions in company common stock. On February 3, 2026, she exercised stock options covering 489 shares at $45.65 and 509 shares at $48.65, converting them into common stock.
On the same date, Miller disposed of 362 shares at $61.89 and 402 shares at $61.83, with all holdings reported as directly owned. After these transactions, she held 10,082 shares of Zions common stock. The underlying option grants have a graded vesting schedule, meaning different tranches become exercisable at different times.
Zions Bancorporation, National Association reported insider transactions by President & COO Scott J. McLean on February 2, 2026. McLean exercised multiple stock options for 1,955 and 11,665 shares at $51.17, and 2,190 and 17,315 shares at $45.65.
He then sold 11,665 shares at a weighted average price of $61.143 and 17,315 shares at $61.147, both executed in multiple trades within narrow price ranges. After these exercises and sales, McLean directly owned 84,440 shares of Zions common stock.
Zions Bancorporation executive vice president Derek Steward reported an option exercise and related stock sale. On February 2, 2026, he exercised a stock option for 769 shares of common stock at $51.17 per share and then sold 769 shares at $60.46 per share. After these transactions, he directly owned 14,307 shares of Zions Bancorporation common stock. The exercised option carried a graded vesting schedule, with exercisability varying by tranche.
Eric Ellingsen, Executive VP and Division CEO of Zions Bancorporation, reported an option exercise and matching share sale. On February 2, 2026, he exercised stock options for 1,519 shares of common stock at $51.17 per share and acquired those shares.
On the same date, he sold 1,519 common shares at $61.265 per share, leaving him with 40,361 shares of common stock held directly after the transactions. The exercised stock option, with a graded vesting schedule, covered 1,519 underlying shares and now shows zero remaining derivative securities.
Zions Bancorporation insider plans to sell 11,663 common shares under Rule 144. The shares are to be sold through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $721,751.09.
The seller acquired these 11,663 shares on 02/03/2026 by exercising stock options originally granted on 03/01/2019 and paid the exercise price in cash. The filing notes that 147,641,034 shares of this class were outstanding, providing context for the planned sale size.